Prenetics Global Q4 Earnings Call Highlights

Prenetics Global (NASDAQ:PRE) used its fourth-quarter and full-year 2025 earnings call to detail what Chief Executive Officer ...
ascopubs.org

INTERCEPT Program of circulating tumor DNA (ctDNA) testing for minimal residual disease (MRD) in colorectal cancer (CRC): Results from a prospective clinical cohort.

Prognostic value of circulating tumor DNA following local therapy in colorectal cancer with liver metastases. Diagnostic performance of endoscopy and MRI in identifying true response among patients ...

NeoGenomics Introduces PanTracer Pro to Support Timely, Informed Solid Tumor Therapy Selection

NeoGenomics launches PanTracer Pro, designed to help clinicians navigate complex molecular testing and support informed solid tumor decisions.

Want a tall, smart child? How IVF tests are selling a dream

Prospective parents are being marketed genetic tests that claim to predict which IVF embryo will grow into the tallest, ...
eLife

EOLA1, a novel mitochondria-localized protein critical for heart functions via regulating mitochondrial translation

Mitochondria possess their own mRNA translation system, mediated by specialized mitoribosomes. Dysregulation of mitochondrial translation disrupts metabolic homeostasis and is linked to various ...
Scientific Research Publishing

Intracranial Suppurations: A Review of 201 Cases at Donka National Hospital, Guinea ()

This retrospective study analyzes the clinical presentation, diagnosis, management, and outcomes of 201 patients with intracranial suppurations at Donka National Hospital in Guinea. The authors report ...